Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy

Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy

Abstract Background This study aims to evaluate the two-year outcomes of polypoidal choroidal vasculopathy (PCV) treated with conbercept and to investigate the predictive response factors. Methods Consecutive patients with PCV who received three-loading intravitreal conbercept, followed by as-needed...

Full description

Bibliographic Details
Main Authors: Yang Liu, Jingli Guo, Wenyi Tang, Gezhi Xu, Wei Liu
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Ophthalmology
Subjects:
Polypoidal choroidal vasculopathy
Conbercept
anti-VEGF
Treatment effect
Online Access:https://doi.org/10.1186/s12886-024-03687-0

Internet

https://doi.org/10.1186/s12886-024-03687-0

Similar Items